Mosaic ImmunoEngineering CPMV
OTC CPMV
$0.51 +0.44 (+596.85%)
As of: Aug 21, 2026 · 9:30 AM EDT

Mosaic ImmunoEngineering (CPMV) Non Operating Investment Income (2010 - 2013)

Mosaic ImmunoEngineering (CPMV) posted quarterly Non Operating Investment Income of -$347.0 for Q4 2013, down 100.62% quarter-over-quarter from $55873.0 in Q3 2012.

Mosaic ImmunoEngineering (CPMV) Non Operating Investment Income (2010 - 2013) Analysis & Trends

Mosaic ImmunoEngineering's Non Operating Investment Income history runs 4 years deep, the most recent figure standing at -$347.0 for Q4 2013.

  • In Q4 2013, Non Operating Investment Income changed N/A year-over-year to -$347.0; the TTM figure through Nov 2014 stood at -$347.0 (changed 0.0% YoY), while the FY2018 annual figure was -$242615.0, down 121.0% from the prior year.
  • Non Operating Investment Income for Q4 2013 stood at -$347.0, down from $55873.0 in the prior quarter.
  • The five-year high for Non Operating Investment Income was $268394.0 in Q2 2012, with the low at -$648740.0 in Q3 2010.
  • The 4-year median for Non Operating Investment Income is $40054.0 (2012), against an average of -$28271.6.
  • The sharpest annual moves came in 2011 and 2012: Non Operating Investment Income jumped 106.01% in 2011, then decreased 16.31% in 2012.
  • Mosaic ImmunoEngineering's Non Operating Investment Income stood at -$648740.0 in 2010, then surged by 106.01% to $39005.0 in 2011, then jumped by 43.25% to $55873.0 in 2012, then sank by 100.62% to -$347.0 in 2013.
  • Business Quant data shows CPMV's Non Operating Investment Income at -$347.0 in Q4 2013, $55873.0 in Q3 2012, and $268394.0 in Q2 2012.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Mosaic ImmunoEngineering 3.68 Mn 3.68 Mn - -

Historic Data

Download Data
DateValue
Nov 30, 2013 -347.00
Nov 30, 2013 -347.00
Aug 31, 2012 55,873.00
Aug 31, 2012 55,873.00
May 31, 2012 268,394.00
May 31, 2012 268,394.00
Feb 29, 2012 40,054.00
Feb 29, 2012 40,054.00
Aug 31, 2011 39,005.00
Aug 31, 2011 39,005.00
Feb 28, 2011 47,860.00
Feb 28, 2011 47,860.00
Aug 31, 2010 -648,740.00
Aug 31, 2010 -648,740.00